Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies

References

• WHO. Global progress report on HIV, viral sexually transmitted infections. World Health Organization; 2021 [cited 2022 Oct 21]. Available from: https://www.who.int/publications/i/item/9789240027077.
   Google Scholar
• Thomas DL. Global elimination of chronic hepatitis. N Engl J Med. 2019;380:2041–2050.
   PubMed Web of Science ®Google Scholar
• Glebe D, Goldmann N, Lauber C, et al. HBV evolution and genetic variability: impact on prevention, treatment and development of antivirals. Antiviral Res. 2021;186:104973. doi:10.1016/J.ANTIVIRAL.2020.104973.
   PubMed Web of Science ®Google Scholar
• Candotti D, Assennato SM, Laperche S, et al. Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose. Gut. 2019;68:313–321.
   PubMed Web of Science ®Google Scholar
• Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016;64:S4–S16.
   PubMed Web of Science ®Google Scholar
• Heermann KH, Goldmann U, Schwartz W, et al. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol. 1984;52:396–402.
   PubMed Web of Science ®Google Scholar
• Glebe D, Bremer C. The molecular virology of hepatitis B virus. Semin Liver Dis. 2013;33:103–112.
   PubMed Web of Science ®Google Scholar
• Ghany MG, Ayola B, Villamil FG, et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology. 1998;27:213–222.
   PubMed Web of Science ®Google Scholar
• Carman WF, Karayiannis P, Waters J, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336:325–329.
   PubMed Web of Science ®Google Scholar
• Lazarevic I. Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol. 2014;20:7653–7664.
   PubMed Web of Science ®Google Scholar
• Coppola N, Loquercio G, Tonziello G, et al. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. J Clin Virol. 2013;58:315–317.
   PubMed Web of Science ®Google Scholar
• Echevarría JM, Avellón A. Hepatitis B virus genetic diversity. J Med Virol. 2006;78(Suppl 1):S36–42. doi:10.1002/JMV.20605.
   PubMedGoogle Scholar
• World Health Organization. Combating hepatitis B and C to reach elimination by 2030: advocacy brief; 2016 [cited 2022 Oct 28]. Available from: https://apps.who.int/iris/handle/10665/206453.
   Google Scholar
• Yip TCF, Wong VWS, Wong GLH. Alanine aminotransferase level: the road to normal in 2021. Hepatol Commun. 2021;5:1807–1809.
   PubMed Web of Science ®Google Scholar
• Valenti L, Pelusi S, Bianco C, et al. Definition of healthy ranges for alanine aminotransferase levels: a 2021 update. Hepatol Commun. 2021;5:1824–1832.
   PubMed Web of Science ®Google Scholar
• Salpini R, Alteri C, Cento V, et al. Snapshot on drug-esistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. J Med Virol. 2013;85:996–1004.
   PubMed Web of Science ®Google Scholar
• Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406–25. doi:10.1093/oxfordjournals.molbev.a040454.
   PubMed Web of Science ®Google Scholar
• Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–2729.
   PubMed Web of Science ®Google Scholar
• Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol. 1993;10:512–26. doi:10.1093/oxfordjournals.molbev.a040023.
   PubMed Web of Science ®Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30:2114.
   PubMed Web of Science ®Google Scholar
• Salpini R, Piermatteo L, Battisti A, et al. A hyper-glycosylation of HBV surface antigen characterizes immunosuppression-driven HBV reactivation and hinders HBsAg recognition in vitro. J Hepatol. 2018;68:S765–S766.
   Web of Science ®Google Scholar
• Salpini R, Battisti A, Piermatteo L, et al. Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection. Emerg Microbes Infect. 2020;9:928–939.
   PubMed Web of Science ®Google Scholar
• Stramer SL, Wend U, Candotti D, et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med. 2011;364:236–247.
   PubMed Web of Science ®Google Scholar
• Hsu HY, Chang MH, Liaw SH, et al. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology. 1999;30:1312–1317.
   PubMed Web of Science ®Google Scholar
• Yan B, Lv J, Feng Y, et al. Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China. Sci Rep. 2017;7:6669. doi:10.1038/S41598-017-07085-Z.
   PubMed Web of Science ®Google Scholar
• Tsutsumi Y, Yamamoto Y, Shimono J, et al. Hepatitis B virus reactivation with rituximab-containing regimen. World J Hepatol. 2013;5:612.
   PubMedGoogle Scholar
• Martel N, Cotte L, Trabaud MA, et al. Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape. J Infect Dis. 2012;205:1757–1761.
   PubMed Web of Science ®Google Scholar
• Ceccarelli L, Salpini R, Sarmati L, et al. Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy. J Infect. 2012;65:180–183.
   PubMed Web of Science ®Google Scholar
• Milazzo L, Ebranati E, Cattaneo D, et al. Recurrence of another hepatitis B virus escape mutant comes back in a patient infected with HIV and low CD4 + count. J Med Virol. 2014;86:97–101.
   PubMed Web of Science ®Google Scholar
• Washizaki A, Murayama A, Murata M, et al. Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen. Nat Commun. 2022;13:1–12.
   PubMed Web of Science ®Google Scholar
• Diaz-Mitoma F, Popovic V, Spaans JN. Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with engerix-B® in healthy Asian adults: a phase 3 randomized clinical trial. Vaccine. 2021;39:3892–3899.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Langley JM, Segall N, et al. Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2021;21:1271–1281.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Finn A, van Damme P, et al. Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine: a phase 3 randomized clinical trial. JAMA Netw Open. 2021;4:e2128652. doi:10.1001/JAMANETWORKOPEN.2021.28652.
   PubMed Web of Science ®Google Scholar
• Knolle PA, Huang LR, Kosinska A, et al. Improving therapeutic vaccination against hepatitis B—insights from preclinical models of immune therapy against persistent hepatitis B virus infection. Vaccines (Basel). 2021;9:1333. doi:10.3390/VACCINES9111333.
   PubMed Web of Science ®Google Scholar
• Fung S, Choi HSJ, Gehring A, et al. Getting to HBV cure: the promising paths forward. Hepatology. 2022;76:233–250.
   PubMed Web of Science ®Google Scholar
• Sticchi L, Caligiuri P, Cacciani R, et al. Epidemiology of HBV S-gene mutants in the Liguria Region. Italy. 2013;9:568–571. doi:10.4161/hv.23236.
   Google Scholar
• Cornberg M, Wong VW-SS, Locarnini S, et al. The role of quantitative hepatitis B surface antigen revisited. J Hepatol. 2017;66:398–411.
   PubMed Web of Science ®Google Scholar
• Höner zu Siederdissen C, Cornberg M. The role of HBsAg levels in the current management of chronic HBV infection; 2014 [cited 2018 Aug 31]. Available from: www.annalsgastro.gr.
   Google Scholar
• Lampertico P, Agarwal K, Berg T, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–398.
   PubMed Web of Science ®Google Scholar
• Luongo M, Critelli R, Grottola A, et al. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy. J Clin Virol. 2015;62:89–91.
   PubMed Web of Science ®Google Scholar
• Tacke F, Amini-Bavil-Olyaee S, Heim A, et al. Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient. J Clin Virol. 2007;38:353–357.
   PubMed Web of Science ®Google Scholar